Insider Trading Alert - RRD, DPS And CI Traded By Insiders
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Crame.
Yesterday, March 10, 2015, 98 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,617.00 to $5,999,989.08.
Highlighted Stocks Traded by Insiders:
RR Donnelley & Sons (RRD) - FREE Research Report
Hamilton Judith H, who is Director at RR Donnelley & Sons, sold 20,000 shares at $19.70 on March 10, 2015. Following this transaction, the Director owned 93,047 shares meaning that the stake was reduced by 17.69% with the 20,000-share transaction.
The shares most recently traded at $19.46, down $0.24, or 1.24% since the insider transaction. Historical insider transactions for RR Donnelley & Sons go as follows:
- 4-Week # shares sold: 39,800
- 12-Week # shares sold: 39,800
- 24-Week # shares sold: 39,800
The average volume for RR Donnelley & Sons has been 1.7 million shares per day over the past 30 days. RR Donnelley & Sons has a market cap of $3.9 billion and is part of the services sector and diversified services industry. Shares are up 15.32% year-to-date as of the close of trading on Tuesday.
R.R. Donnelley & Sons Company provides integrated communications solutions to private and public sector clients in the United States and internationally. The company operates through Publishing and Retail Services, Variable Print, Strategic Services, and International segments. The stock currently has a dividend yield of 5.28%. The company has a P/E ratio of 33.4. Currently, there are no analysts who rate RR Donnelley & Sons a buy, no analysts rate it a sell, and 1 rates it a hold.
Exclusive Offer: Get the latest Stock Analysis on RRD - FREE
rates RR Donnelley & Sons as a
. The company's strengths can be seen in multiple areas, such as its revenue growth and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full
RR Donnelley & Sons Ratings Report
from
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Dr Pepper Snapple Group (DPS) - FREE Research Report
Johnston James J. JR, who is Executive Vice President at Dr Pepper Snapple Group, sold 12,296 shares at $78.86 on March 10, 2015. Following this transaction, the Executive Vice President owned 87,709 shares meaning that the stake was reduced by 12.3% with the 12,296-share transaction.
Hancock Philip L, who is Executive Vice President at Dr Pepper Snapple Group, sold 4,919 shares at $78.05 on March 10, 2015. Following this transaction, the Executive Vice President owned 4,142 shares meaning that the stake was reduced by 54.29% with the 4,919-share transaction.
The shares most recently traded at $77.11, down $0.94, or 1.22% since the insider transaction. Historical insider transactions for Dr Pepper Snapple Group go as follows:
- 4-Week # shares sold: 7,726
- 12-Week # shares sold: 7,726
- 24-Week # shares sold: 166,309
The average volume for Dr Pepper Snapple Group has been 1.5 million shares per day over the past 30 days. Dr Pepper Snapple Group has a market cap of $15.2 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 8.75% year-to-date as of the close of trading on Tuesday.
Dr Pepper Snapple Group, Inc. operates as a brand owner, manufacturer, and distributor of non-alcoholic beverages in the United States, Canada, Mexico, and the Caribbean. The company operates through three segments: Beverage Concentrates, Packaged Beverages, and Latin America Beverages. The stock currently has a dividend yield of 2.44%. The company has a P/E ratio of 22.1. Currently, there are no analysts who rate Dr Pepper Snapple Group a buy, 3 analysts rate it a sell, and 10 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on DPS - FREE
rates Dr Pepper Snapple Group as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, solid stock price performance, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full
Dr Pepper Snapple Group Ratings Report
from
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Cigna (CI) - FREE Research Report
Manders Matthew G, who is Pres. US Comm Mkts & Gbl HC Op at Cigna, sold 15,263 shares at $120.95 on March 10, 2015. Following this transaction, the Pres. US Comm Mkts & Gbl HC Op owned 50,827 shares meaning that the stake was reduced by 23.09% with the 15,263-share transaction.
The shares most recently traded at $120.29, down $0.66, or 0.55% since the insider transaction. Historical insider transactions for Cigna go as follows:
- 4-Week # shares sold: 466
- 12-Week # shares sold: 940
- 24-Week # shares sold: 14,808
The average volume for Cigna has been 1.4 million shares per day over the past 30 days. Cigna has a market cap of $31.5 billion and is part of the health care sector and health services industry. Shares are up 16.42% year-to-date as of the close of trading on Tuesday.
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. The stock currently has a dividend yield of 0.03%. The company has a P/E ratio of 15.6. Currently, there are 9 analysts who rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on CI - FREE
rates Cigna as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full
from
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
null